Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1490-1495, doi:10.1016/j.jacc.2007.02.035 (Published online 20 March 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sick, P. B.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sick, P. B.
Right arrow Articles by Holmes, D. R.
Related Collections
Right arrowRelated Article

Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation

Peter B. Sick, MD*,*, Gerhard Schuler, MD{dagger}, Karl Eugen Hauptmann, MD{ddagger}, Eberhard Grube, MD, FACC§, Steve Yakubov, MD, FACC||, Zoltan G. Turi, MD, FACC, Gregory Mishkel, MD, FACC#, Steve Almany, MD, FACC** and David R. Holmes, MD, FACC{dagger}{dagger}

* Krankenhaus der Barmherzigen Brüder, Regensburg, Germany
{dagger} University of Leipzig, Heart Center GmbH, Leipzig, Germany
{ddagger} Krankenhaus der Barmherzigen Brüder, Trier, Germany
§ Heart Center Siegburg, Siegburg, Germany
|| Midwest Cardiology Research Foundation, Riverside Methodist Hospital, Columbus, Ohio
Cooper Hospital, Camden, New Jersey
# Prairie Education and Research, Springfield, Illinois
** William Beaumont Hospital, Cardiology Center, Royal Oak, Michigan
{dagger}{dagger} Mayo Clinic, St. Mary’s Hospital, Rochester, Minnesota.


Figure 1
View larger version (33K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 WATCHMAN Implant

WATCHMAN device, nitinol cage with a polytetrafluoroethylene membrane on the surface, and fixation barbs around the perimeter

 

Figure 2
View larger version (66K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Introduction Sheath With Double and Single Curve for Different Anatomical Situations

Introducer sheaths with different shapes

 

Figure 3
View larger version (97K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Six-Month TEE Control With a Well-Positioned WATCHMAN Device in the LAA

Little color flow is seen behind the device, and no flow around the margins. LAA = left atrial appendage; TEE = transesophageal echocardiography

 

Figure 4
View larger version (56K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Layered Thrombus Formation on the Device 6 Months After Implantation

LA = left atrial.

 

Figure 5
View larger version (125K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Anatomical View of the WATCHMAN Device in the LAA in a Patient Who Died From Aortic Dissection

This patient died 9 months after implantation. Stable position and endothelialization of the device were confirmed. LAA = left atrial appendage. Reproduced with permission from K. E. Hauptmann, Trier, Germany.

 

Figure 6
View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Flow Chart of the Trial With Number of Implants and Attempts as Well as Drop Outs Dependent on Generation of Device

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement